Call for papers - Treatment-resistant psychiatric disorders

Luisella Bocchio-Chiavetto, PhD, eCampus University, IRCCS San Giovanni di Dio Research Centre, Italy

Professor Luisella Bocchio-Chiavetto is a Full Professor of Experimental Biology in the Department of Theoretical and Applied Sciences at eCampus University and research collaborator at the Psychiatric Unit of IRCCS San Giovanni di Dio Research Centre. Her primary area of research includes the molecular basis of etiology and treatment response in major psychosis.

Her main fields have been the role of immune system modulators and neurotrophic factors in the pathogenesis and in the action mechanism of pharmacological and non-pharmacological therapies. More recently her studies are focused on the possible involvement of microRNAs and metabolic/immune alterations in mood disorders, first episode psychosis, and personality disorders as well as the identification of biomarkers for differential diagnosis and personalization of pharmacological and psychotherapeutic treatments. She also serves as an Editorial Board Member for BMC Psychiatry.

Ebenezer Oloyede, MPharm, PhD, University of Oxford, UK

Dr Ebenezer Oloyede is the Principal Pharmacist at the South London and Maudsley NHS Foundation Trust, and an honorary lecturer in the Institute of Psychiatry, Psychology & Neuroscience at King's College London. His clinical expertise is in the use of psychotropic medication in early intervention in psychosis, and his academic research focusses on epidemiology and population research in treatment-resistant psychosis. 

 

Eromona Whiskey, BPharm, PhD, South London & Maudsley NHS Foundation Trust, King's College London, UK

Dr Eromona Whiskey is a Consultant Mental Health Pharmacist at the South London and Maudsley NHS Foundation Trust and an Honorary Senior Lecturer in the Institute of Pharmaceutical Sciences at King's College London. He has more than 25 years’ experience in the pharmacotherapy of schizophrenia. Dr Whiskey is a member of the Expert Psychopharmacology Group of the National Psychosis Service at the South London & Maudsley NHS Foundation Trust and a former head of the National Psychotropic Medicines Information Service at the same institution. Dr Whiskey is a regular contributor to the highly influential Maudsley Prescribing Guidelines.  His main research interest is in psychopharmacology of refractory psychotic disorders, an area in which he has published widely.  He is a notable speaker at national and international psychopharmacology conferences.